News

Lorelei McGlynn's $1.46M Stake Offload From Henry Schein

Lorelei McGlynn's $1.46M Stake Offload From Henry Schein

What to Know About Lorelei McGlynn’s Recent Insider Sale

A recent SEC filing shows that Lorelei McGlynn, Senior Vice President at Henry Schein HSIC, sold company stock in a sizable insider transaction.

In total, McGlynn sold 21,035 shares of Henry Schein, for proceeds of $1,457,725. The move naturally prompts questions about how insiders view the business and where the stock might go next. One note for perspective: an insider sale is a useful data point, not a verdict on the company’s future.

Henry Schein, in Brief

Henry Schein Inc. supplies dental and medical professionals with what they need to run their practices, pairing human know?how with modern technology. The company operates in two main segments: healthcare distribution and technology & value?added services. The distribution business brings together global dental and medical operations, delivering everyday supplies, equipment, and related health products to office?based practitioners and other care settings. Its technology and services offerings layer on tools and support that help practices work smarter and more efficiently.

Reading the Financials

Revenue: In the first three months of the current fiscal year, revenue grew 1.16%. That’s growth, though it trails the pace set by many industry peers.

Profitability:

  • Gross margin: At 32.46%, gross margin points to solid cost control and healthy unit economics, outpacing a number of competitors.

  • Earnings per share (EPS): EPS of 0.81 lands below typical industry expectations, suggesting the bottom line hasn’t fully matched the revenue framework.

Balance sheet and debt: A debt?to?equity ratio of 0.81 indicates a balanced capital structure, with debt levels that appear manageable relative to equity.

Valuation:

  • Price/Earnings (P/E): The current P/E of 25.42 is lower than the industry average, which can be read as potentially more attractive pricing for the stock if earnings hold up.

  • Price/Sales (P/S): The P/S ratio sits at 0.72, which may point to a possibly inflated valuation in light of sales performance, depending on how investors weigh growth and margins.

  • EV/EBITDA: At 13.41, this multiple is above industry benchmarks, suggesting the market assigns a confident value to earnings before interest, taxes, depreciation, and amortization.

Scale: By market capitalization, Henry Schein is positioned below the average of its competitor set, reflecting a relatively smaller footprint versus larger peers.

How to Think About Insider Trading Activity

Insider trades can be informative, but they shouldn’t be the only lens for an investment decision. Company officers and directors must report most transactions within two business days on Form 4. The direction of a trade can hint at sentiment—insider buying often signals confidence, while selling invites a closer look at context, timing, and personal diversification needs. In short, treat these filings as one piece of a broader mosaic that includes fundamentals, valuation, and market conditions.

During choppy markets especially, tracking insider activity alongside core financial metrics can help you build a clearer, more measured view.

Making Sense of Transaction Codes

Form 4 filings use standardized codes to describe what happened:

P marks a purchase, while S marks a sale. Two other common codes are C for an option conversion and A for an award or grant of securities. Those small letters carry big meaning—understanding them helps you read not just that a trade occurred, but why and how it was executed.

Frequently Asked Questions

Why did Lorelei McGlynn sell shares?

The SEC filing records her decision to sell a significant block of Henry Schein shares. The filing confirms the sale but doesn’t state a reason, so it’s best viewed as one data point rather than a definitive signal.

What exactly does Henry Schein do?

Henry Schein serves dental and medical practitioners with supplies, equipment, and technology. Its two segments—healthcare distribution and technology & value?added services—work together to help practices operate efficiently and deliver care.

How are Henry Schein’s recent results?

Revenue grew 1.16% in the first three months of the current fiscal year. Gross margin is 32.46%, EPS is 0.81, and the debt?to?equity ratio is 0.81. These figures show steady operations, though EPS and growth trail typical industry levels.

What can I infer from insider trades like this?

Insider trades can hint at executive sentiment. Purchases (P) often read as optimism; sales (S) call for added context. Use them alongside financial performance and valuation rather than as a stand?alone signal.

How is the stock valued in the market right now?

Key markers include a P/E of 25.42, P/S of 0.72, and EV/EBITDA of 13.41, with market capitalization below the peer average. Together, these metrics offer a snapshot of how investors are pricing Henry Schein relative to its earnings, sales, and scale.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Linkind's Light Stick Revolutionizes Retail Lighting Experience

Updated Category News Views 5

Transforming Lighting in Retail Spaces Folks, let's talk lighting. Not the humdrum switch-you-on kind, but something much snazzier, more customized, and downright interactive. I'm talking about Linkind's latest brainchild—the Smart Light Stick. Launched amidst the neon rush of tm:rw in New York City, this gizmo isn't just another bulb in the home improvement aisle. It's...

Continue Reading
Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 6

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
Omneky Integrates AI Growth Agent With Slack for Ads

Updated Category News Views 5

Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...

Continue Reading
Beetles Gel Polish Unveils Vibrant Fall Nail Carnival

Updated Category News Views 6

Beetles Gel Polish Launches Fall Nail Carnival Here comes a new twist on fall fashion, and no, it ain’t your grandma's knitted sweater. We're talking nail polish—a vibrant, flashy ordeal brought to you by Beetles Gel Polish with their Fall Nail Carnival. They're rolling out this spectacle not just for your visions of grandeur nail ideas, but for those seeking deals...

Continue Reading
Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
WareSpace Expands Reach With $36.5M Acquisitions

Updated Category News Views 3

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 3

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 6

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading
Andover Audio's FreePlay: Stereo Sound Goes Portable

Updated Category News Views 7

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Continue Reading

Top 5 Most Recently Viewed Articles

How Smart Money Is Investing in Norwegian Cruise Line's Options

Updated Category News Views 144

The Rise of Norwegian Cruise Line in Options Trading Recently, investors with substantial resources have displayed an optimistic outlook towards Norwegian Cruise Line. Recent Trades Indicate Bullish Sentiment Examining the trade history for Norwegian Cruise Line NCLH, we found evidence of 11 trades being executed. Among these trades, 54% reflect a bullish sentiment while...

Continue Reading
Empowering Women with Doctor's Best New Multi-Vitamin Launch

Updated Category News Views 190

Doctor's Best Introduces a Groundbreaking Women's Multi-Vitamin Doctor's Best Inc., a renowned nutritional supplement company, has recently unveiled its latest product, designed specifically for women. The Women's Multi-Vitamin promises to provide 21 essential nutrients that support everyday health and wellness for women throughout all life stages. Features of the New...

Continue Reading
Processa Pharmaceuticals' Latest Updates on Drug Pipeline

Updated Category News Views 93

Processa Pharmaceuticals Offers Update on Product Pipeline and Financial Performance Phase 2 trial with NGC-Cap for breast cancer is currently in progress The Phase 1b trial of NGC-Cap showed a favorable safety profile along with preliminary signs of anti-tumor activity Preclinical studies indicate that NGC-Iri delivers a higher concentration of cancer-fighting SN-38...

Continue Reading
Globant's 2025 Q1 Revenue Growth and Strategic Focus

Updated Category News Views 848

Globant's Remarkable Financial Performance for Q1 2025 Globant (NYSE: GLOB), a leader in technology-enabled business transformation, has reported a strong performance for the first quarter of 2025. The company achieved revenues of $611.1 million, marking a 7.0% increase compared to the same period last year. This notable growth reflects Globant's commitment to leveraging...

Continue Reading
Promising Long-Term Effects of LEQEMBI on Alzheimer's Patients

Updated Category News Views 164

New Insights on LEQEMBI's Impact on Alzheimer's Disease Recent clinical data reveals significant findings regarding LEQEMBI (lecanemab-irmb) and its long-term benefits for patients with early-stage Alzheimer's disease (AD). Presenting these insights at a notable conference marked a key moment for both Eisai Co., Ltd. and Biogen Inc. These findings highlight how LEQEMBI...

Continue Reading